The 16 drug brands that ran campaigns spent a total of $271.6 million, or about 71% of the total $380 million among first-time advertisers, according to an analysis of viewership data by the trade group VAB.
“A significant number of bold, first-time advertisers that provide products or services addressing essential consumer needs such as pharma, financial services and apparel,” VAB said in its report. “Brands that launch multiscreen TV campaigns reach broader audiences which builds brand interest, consideration and engagement.”